Granulocyte-macrophage colony-stimulating factor in the management of severe ecthyma gangrenosum related to myelodysplastic syndrome

Arch Dermatol. 1995 Aug;131(8):892-4. doi: 10.1001/archderm.1995.01690200026005.

Authors

P A Bécherel¹, O Chosidow, E Berger, S Martin, D Khayat, S Herson, C Francès

Affiliation

¹ Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

PMID: 7632059
DOI: 10.1001/archderm.1995.01690200026005

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Anti-Bacterial Agents
Drug Therapy, Combination / therapeutic use
Ecthyma / complications
Ecthyma / drug therapy*
Ecthyma / microbiology
Female
Gangrene
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Humans
Myelodysplastic Syndromes / complications
Myelodysplastic Syndromes / drug therapy*
Neutropenia / complications
Pseudomonas Infections / drug therapy
Pseudomonas Infections / microbiology
Pseudomonas aeruginosa / isolation & purification

Substances

Anti-Bacterial Agents
Granulocyte-Macrophage Colony-Stimulating Factor